Beta Bionics, Inc. has grown revenue 189% a year over three years and 189% a year over five. Revenue growth, 3-year annual rate: +189% (Medical Devices median +12%). Revenue growth, 5-year rate: +189%, growth has slowed since the five-year average. Years of annual history on file: 3, FY2023 to FY2025, as filed.

BBNXBeta Bionics, Inc.

Healthcare

$17.44-21% 1Y

$17.44

$8.8652 weeks$31.99

Is it growing?

Good

Growing: revenue growing +53% year on year and operating margin widening (+10.1 points).

2 good, 1 without data

Revenue trend+53% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+10.1 points operating

Trailing-twelve-month operating margin, -70.1% now against -80.2% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BBNX growing?

Beta Bionics, Inc. has grown revenue 189% a year over three years and 189% a year over five.

+189%

Revenue growth, 3-year annual rate · Medical Devices median +12% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +189%
Revenue growth, 5-year rate · +189% over three · growth has slowed since the five-year average
Years of annual history on file: 3
Years of annual history on file · FY2023 to FY2025, as filed

Details›